The country had the highest number of deaths from diabetes in the Western Pacific region, at approximately 1.4 million, and the second-highest diabetes-related health expenditure in the world, at 165.3 billion USD
97 These new GLP-1 RAs, including dual and triple agonists, are now in Phase 3 trials, and the clinical use of more potent GLP-1 RAs with additional indications is expected
investigated -MSH-derived peptides including KPV for their anti-inflammatory properties and inhibition of NF-B-dependent cytokine pathways
Compounded semaglutide works because the active ingredient is the same as Ozempic and Wegovy
As the science continues to evolve, were seeing that these benefits may extend to people who dont necessarily need to lose weight, and thats opened up an interesting conversation about why people are microdosing GLP-1 medications
10.1038/s41574-020-00459-w Nat